LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $916,630 | -59.6% | 615,188 | -38.3% | 0.00% | – |
Q2 2023 | $2,271,662 | +13.3% | 996,343 | -2.6% | 0.00% | – |
Q1 2023 | $2,005,289 | +19.5% | 1,023,107 | 0.0% | 0.00% | – |
Q4 2022 | $1,677,895 | -18.0% | 1,023,107 | 0.0% | 0.00% | – |
Q3 2022 | $2,046,000 | -8.2% | 1,023,107 | -0.9% | 0.00% | – |
Q2 2022 | $2,229,000 | -34.2% | 1,032,083 | +87.7% | 0.00% | – |
Q4 2021 | $3,388,000 | – | 550,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,282,084 | $4,929,000 | 4.16% |
Perceptive Advisors | 56,560,211 | $122,170,000 | 3.83% |
SCHF (GPE), LLC | 937,500 | $2,025,000 | 2.99% |
VR Adviser, LLC | 5,378,341 | $11,617,000 | 2.29% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,314,173 | $7,159,000 | 0.52% |
Affinity Asset Advisors, LLC | 450,000 | $972,000 | 0.41% |
Altium Capital Management LP | 315,191 | $681,000 | 0.27% |
RA Capital Management | 4,622,574 | $9,985,000 | 0.27% |
22NW, LP | 141,223 | $305,000 | 0.16% |
Logos Global Management LP | 394,486 | $852,000 | 0.16% |